| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.24 | 0.1 |